www.interpharma.co.th 6. Approve to present to the Shareholders' Meeting to consider and approve the issuance of debentures in the amount not exceeding 300 million Baht. The total debt burden of the Company at any one
: 1. Approved to propose to the Extraordinary General Meeting of Shareholders No .1 /2018 to consider and approve the reduction of the Company’s registered capital in the amount of THB 36,184,761.50
right to vote. However, shareholders who have conflict of interest in this issue are excluded from the vote. The Company also needs to prepare the disclosure of informatio transaction from shareholders
December 2017 Transaction amount Baht 30,153,785 Pricing policy At Book value (transaction amount) and near market value Payment term By cash with 60 days of credit term The reason In consider to support the
Section 7 Securities and Exchange Act B.E. 2535 Section 7. The Minister of Finance shall be in charge of the enforcement of this Act and shall have the power to issue ministerial regulations and
Shareholder No.1/2019 Agenda 2 To acknowledge the report on the Company’s operating result for the year 2019 Agenda 3 To acknowledge interim payment Agenda 4 To consider and approve the financial statement of
issue in Cal-Comp Technology (Philippines) Inc. 3) To consider any other business (if any). The Board of Directors had also approved the Record Date on June 13, 2017 and collects the names of shareholders
conflict of interest in this issue are excluded from the vote. The Company also needs to prepare the disclosure of information memorandum. In order to approve this connected transaction from shareholders